Belle Mead, NJ, United States of America

Peter Henry Schafer

This inventor holds 40 USPTO granted patents and 29 published patent applications and 26 EPO patents, primarily in Immune Disease Treatment. Top assignees: Celgene Corporation, Amgen Inc., Celgene International Ii Sarl. Active years: 2005-2024.

USPTO Granted Patents = 40 (Patent Applications = 29)

% Patents Active = 77.5

EPO Patents = 26 (Patent Applications = 24)

Average Co-Inventor Count = 3.7

ph-index = 14

Forward Citations = 438(Granted Patents)

Location History:

Sommerset, NJ (US) (2007)
Randolph, NJ (US) (2014)
Somerset, NJ (US) (2005 - 2021)
Belle Mead, NJ (US) (2015 - 2024)

Company Filing History:

Celgene International Ii Sarl

patents

Years Active: 2005-2024

Loading Chart...

Areas of Expertise:

Systemic Lupus Erythematosus

Biomarkers

Apremilast

Tyk2 Inhibitors

PD-1 Binding Antibodies

Cereblon

PDE4 Inhibitors

Autoimmune Diseases

Isoindoline Compounds

Inflammatory Diseases

Cancer Treatment

Psoriatic Arthritis

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12064437 - Methods for treating systemic lupus erythematosus and the use of biomarkers as a predictor of clinical sensitivity to therapies (2024-08-20),

2. 11660302 - 3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus (2023-05-30),

3. 11524950 - Treatment of immune-related and inflammatory diseases (2022-12-13),

4. 11357775 - Combination therapies comprising apremilast and Tyk2 inhibitors (2022-06-14),

5. 11260046 - (+)-2-[1-(3-Ethoxy-4- methoxyphenyl)-2-methylsulfonylethyl]- 4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof (2022-03-01),

6. 11040024 - Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione (2021-06-22),

7. 10980812 - 3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus (2021-04-20),

8. 10919883 - Treatment of immune-related and inflammatory diseases (2021-02-16),

9. 10751414 - Methods of treating psoriasis using PD-1 binding antibodies (2020-08-25),

10. 10610516 - Methods of using (+)- 2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-dione (2020-04-07),

11. 10596179 - 3-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus (2020-03-24),

12. 10245266 - 3-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus (2019-04-02),

13. 10092542 - Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione (2018-10-09),

14. 10047151 - Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor (2018-08-14),

15. 10018637 - Methods for treating inflammatory and other diseases and the use of biomarkers as predictors of clinical sensitivity to treatment with apremilast (2018-07-10),

Title: Peter Henry Schafer - The Innovative Mind from Belle Mead

Introduction: Peter Henry Schafer is a renowned inventor hailing from Belle Mead, New Jersey. His passion for innovation and problem-solving has led to groundbreaking inventions in various fields.

Latest Patents: Peter Henry Schafer holds several patents in the areas of renewable energy technologies, medical devices, and consumer electronics. His most recent patent is for a cutting-edge sustainable packaging solution that is revolutionizing the industry.

Career Highlights: With a background in engineering and a keen eye for detail, Peter Henry Schafer has had a successful career marked by numerous achievements. He has worked for leading tech companies, where he spearheaded projects that have had a significant impact on the market.

Collaborations: Throughout his career, Peter Henry Schafer has collaborated with top researchers, engineers, and designers to bring his innovative ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Peter Henry Schafer's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions continue to inspire the next generation of innovators to push the boundaries of what is possible.